MARKET

MDCO

MDCO

Medicines
NASDAQ

Real-time Quotes | Nasdaq Last Sale

84.90
-0.06
-0.07%
Delisted 19:47 01/03 EST
OPEN
84.96
PREV CLOSE
84.96
HIGH
84.98
LOW
84.88
VOLUME
15.59M
TURNOVER
--
52 WEEK HIGH
84.98
52 WEEK LOW
18.83
MARKET CAP
6.79B
P/E (TTM)
-27.1073
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MDCO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MDCO News

  • Novartis to speed access to $10 billion heart drug via NHS deal
  • Reuters.01/13 18:04
  • The Medicines Company Announces Effective Date Of Make-Whole Fundamental Change Relating To Its 2.50% Convertible Senior Notes Due 2022, 2.75% Convertible Senior Notes due 2023 and 3.50% Convertible Senior Notes due 2024
  • Business Wire.01/06 18:12
  • Novartis Completes Tender Offer for All Outstanding Shares of The Medicines Company for $85/Share
  • Benzinga.01/06 10:06
  • The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger
  • Benzinga.01/03 12:55

More

Industry

Pharmaceuticals
+0.37%
Pharmaceuticals & Medical Research
+0.53%

Hot Stocks

Name
Price
%Change

About MDCO

The Medicines Company is a global biopharmaceutical company. The Company is focused on advancing the treatment of acute and intensive care patients through the delivery of medicines to the hospital marketplace around the world. It markets Angiomax (bivalirudin), Ionsys (fentanyl iontophoretic transdermal system), Minocin (minocycline) for injection and Orbactiv (oritavancin). It also has a pipeline of products in development, including Carbavance, inclisiran and MDCO-700. Carbavance is used for the treatment of hospitalized patients with gram-negative bacterial infections. Inclisiran is used for the treatment of hypercholesterolemia. MDCO-700 includes sedative-hypnotic, which is used to induce and maintain sedation for procedural care and general anesthesia for surgical care. In addition to these products and products in development, it has a portfolio of generic drugs.
More

Webull offers The Medicines Company (MDCO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.